United Therapeutic (UTHR)
$83.53 0.00 (0.00%)
18:09 EDT UTHR Stock Quote Delayed 15 Minutes
Previous Close $83.53
Market Cap 3.64B
PE Ratio 7.60
Volume (Avg. Vol.)
Day's Range 83.53 - 83.53
52-Week Range 74.31 - 129.59
Dividend & Yield N/A (N/A)
UTHR Stock Predictions, Articles, and United Therapeutic News
- From InvestorPlace
- From the Web
Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 1.8%.
Healthcare stocks declined 2.0% on Wall Street on Monday.
Healthcare stocks finished flat on Monday on Wall Street.
Healthcare stocks finished up 0.6% on Wall Street today.
Healthcare stocks rose 0.3% on Wall Street so far on Tuesday.
Healthcare stocks declined on Wall Street today, down 2.5%.
We're in the year of biotech stocks, which easily outpaced the broad S&P 500. With earnings season in bloom, can they keep the magic alive?
Healthcare stocks finished up broadly on Wall Street on Tuesday, with the sector seeing an overall increase of 0.2%.
Healthcare stocks finished flat today on Wall Street.
Healthcare stocks finished down on Wall Street today, down 1.2%.
Healthcare stocks finished down 0.3% on Wall Street today.
Healthcare stocks rose 0.7% on Wall Street on Thursday morning.
Healthcare stocks rose 0.6% on Wall Street on Wednesday morning.
Healthcare stocks finished up 1.6% on Wall Street on Friday.
Healthcare stocks finished up 0.5% on Wall Street on Thursday.
Harness the volatility of the biotechnology sector by letting stats tell the story. Bank on these three biotech stocks ahead of earnings.
Healthcare stocks advanced 0.7% on Wall Street on Tuesday morning.
Healthcare stocks declined on Wall Street so far on Friday, down 0.9%.
Healthcare stocks advanced 0.4% on Wall Street on Monday morning.
From Seeking Alpha
From Simply Wall St
The external fund manager backed by Berkshire Hathaway’s Charlie Munger, Li Lu, makes no bones about it when he says ‘The biggest investment risk is not the volatility of prices,<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-uthr/united-therapeutics/news/health-check-how-prudently-does-united-therapeutics-nasdaquthr-use-debt/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!